Prospective evaluation of Emergency Department patients with potential coronary syndromes using initial absolute CK-MB vs. CK-MB relative index

Journal of Emergency Medicine

Volumn 24, Issue 4, 2003, Pages 361-367

  Capellan, Otilia ^a   Hollander, Judd E ^a   Pollack Jr , Charles ^b   Hoekstra, James W ^c   Wilke, Eric ^d   Tiffany, Brian ^d   Sites, Frank D ^a   Shofer, Frances S ^a   Gibler, W Brian ^e  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b PENNSYLVANIA HOSPITAL   (United States)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d MARICOPA MEDICAL CENTER   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Acute coronary syndrome; Complications; Creatine kinase; Emergency Depa rtment; Myocardial infarction; Risk stratification

Indexed keywords

CREATINE KINASE MB;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CALCULATION; CARDIOVASCULAR RISK; CLINICAL EXAMINATION; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DEATH; DIAGNOSTIC VALUE; ELECTROCARDIOGRAM; EMERGENCY TREATMENT; EMERGENCY WARD; FEMALE; HEART ARRHYTHMIA; HEART DISEASE; HEART MUSCLE ISCHEMIA; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 0038365422     PISSN: 07364679     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-4679(03)00030-1     Document Type: Article

References (59)

1. Tatum J.L., Jesse R.L., Kontos M.C., et al. Comprehensive strategy for the evaluation and triage of the chest pain patient. Ann Emerg Med. 29:1997;116-125.
2. Storrow A.B., Gibler W.B. The role of cardiac markers in the emergency department. Clin Chim Acta. 284:1999;187-196.
3. Storrow A.B., Gibler W.B. Chest pain centers diagnosis of acute coronary syndromes. Ann Emerg Med. 35:2000;449-461.
4. Kontos M.C., Anderson F.P., Hanbury C.M., Roberts C.S., Miller W.G., Jesse R.L. Use of the combination of myoglobin and CK-MB mass for the rapid diagnosis of acute myocardial infarction. Am J Emerg Med. 15:1997;14-19.
5. Gibler W.B., Young G.P., Hedges J.R., et al. Acute myocardial infarction in chest pain patients with nondiagnostic ECGs serial CK-MB sampling in the emergency department . Ann Emerg Med. 21:1992;504-512.
6. Young G.P., Gibler W.B., Hedges J.R., et al. Serial creatine kinase-MB results are a sensitive indicator of acute myocardial infarction in chest pain patients with nondiagnostic electrocardiograms the second Emergency Medicine Cardiac Research Group Study . Acad Emerg Med. 4:1997;869-877.
7. Dagnone E., Collier C., Pickett W., et al. Chest pain with nondiagnostic electrocardiogram in the emergency department a randomized controlled trial of two cardiac marker regimens . CMAJ. 162:2000;1561-1566.
8. Kontos M.C., Jesse R.L. Evaluation of the emergency department chest pain patient. Am J Cardiol. 85:2000;32B-39B.
9. Lee T.H., Cook E.F., Weisberg M., Sargent R.K., Wilson C., Goldman L. Acute chest pain in the emergency room. Identification and examination of low-risk patients. Arch Intern Med. 145:1985;65-69.
10. Lee T.H., Rouan G.W., Weisberg M.C., et al. Clinical characteristics and natural history of patients with acute myocardial infarction sent home from the emergency room. Am J Cardiol. 60:1987;219-224.
11. Goldman L., Cook E.F., Brand D.A., et al. A computer protocol to predict myocardial infarction in emergency department patients with chest pain. N Engl J Med. 318:1988;797-803.
12. Goldman L., Weinberg M., Weisberg M., et al. A computer-derived protocol to aid in the diagnosis of emergency room patients with acute chest pain. N Engl J Med. 307:1982;588-596.
13. Sarko J., Pollack C.V. Beyond the twelve-lead electrocardiogram diagnostic tests in the evaluation for suspected acute myocardial infarction in the emergency department, part II . J Emerg Med. 16:1998;67-78.
14. Pope J.H., Aufderheide T.P., Ruthazer R., et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med. 342:2000;1163-1170.
15. Green G.B., Beaudreau R.W., Chan D.W., DeLong D., Kelley C.A., Kelen G.D. Use of Troponin T and Creatine Kinase-MB subunit levels for the risk stratification of emergency department patients with possible myocardial ischemia. Ann Emerg Med. 31:1998;19-29.
16. Jayes R.L. Jr, Beshansky J.R., D'Agostino R.B., et al. Do patients' coronary risk factor reports predict acute cardiac ischemia in the emergency department? A multicenter study. J Clin Epidemiol. 45:1992;621-626.
17. Porela P., Pulkki K., Helenius H., et al. Prediction of short-term outcome in patients with suspected myocardial infarction. Ann Emerg Med. 35:2000;413-420.
18. Adams J.E., Abendschein D.R., Jaffe A.S. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation. 88:1993;750-763.
19. Hedges J.R., Young G.P., Henkel G.F., et al. Serial ECGs are less accurate than serial CK-MB results for emergency department diagnosis of myocardial infarction. Ann Emerg Med. 21:1992;1445-1450.
20. Hedges J.R., Young G.P., Henkel G.F., et al. Early CK-MB elevations predict ischemic events in stable chest pain patients. Acad Emerg Med. 1:1994;9-16.
21. Alexander J.H., Sparapani R.A., Mahaffey K.W., et al. Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. JAMA. 283:2000;347-353.
22. Bock J.L., Brogan G.X., McCuskey C.F., et al. Evaluation of CK-MB isoform analysis for early diagnosis of myocardial infarction. J Emerg Med. 17:1999;75-79.
23. Robinson D.J., Christenson R.H. Creatine kinase and its CK-MB isoenzyme the conventional marker for the diagnosis of acute myocardial infarction . J Emerg Med. 17:1999;95-104.
24. Fesmire F.M., Percy R.F., Bardoner J.B., et al. Serial creatine kinase (CK) MB testing during the emergency department evaluation of chest pain utility of a 2-hour ΔCK-MB of +1.6ng/ml . Am Heart J. 136:1998;237-244.
25. Vikenes K., von der Lippe G., Farstad M., et al. Clinical applicability of creatine kinase MB mass and the electrocardiogram versus conventional cardiac enzymes in the diagnosis of acute myocardial infarction. Int J Cardiol. 59:1997;11-20.
26. Sarko J., Pollack C.V. Jr. Beyond the twelve-lead electrocardiogram diagnostic tests in the evaluation for suspected acute myocardial infarction in the emergency department, part II . J Emerg Med. 16:1998;67-78.
27. Young G.P., Gibler W.B., Hedges J.R., et al. Serial Creatine kinase-MB results are a sensitive indicator of acute myocardial infarction in chest pain patients with nondiagnostic electrocardiograms the second emergency medicine cardiac research group study . Acad Emerg Med. 4:1997;869-877.
28. Sax H., Contesse J., Dubach P., Reinhart W.H. Creatine kinase MB during myocardial infarction relationship to preexisting coronary heart disease and medication . Acta Cardiol. 52:1997;423-430.
29. Apple F.S., Christenson R.H., Valdes R. Jr, et al. Simultaneous rapid measurement of whole blood myoglobin, creatine kinase MB, and cardiac troponin I by the triage cardiac panel for detection of myocardial infarction. Clin Chem. 45:1999;199-205.
30. de Winter R.J., Lijmer J.G., Koster R.W., et al. Diagnostic accuracy of myoglobin concentration for the early diagnosis of acute myocardial infarction. Ann Emerg Med. 35:2000;113-120.
31. Polanczyk C.A., Lee T.H., Cook E.F., et al. Value of additional two-hour myoglobin for the diagnosis of myocardial infarction in the emergency department. Am J Cardiol. 83:1999;525-529.
32. Adams J.E., Schechtman K.B., Landt Y., et al. Comparable detection of acute myocardial infarction by creatine kinase MB isoenzyme and cardiac troponin I. Clin Chem. 40:1994;1291-1295.
33. Gerhardt W., Nordin G., Ljungdahl L. Can troponin T replace CK MBmass as "gold standard" for acute myocardial infarction ("AMI")? Scand J Clin Lab Invest Suppl. 59:1999;83-89.
34. Van de Werf F. Cardiac troponins in acute coronary syndromes. N Engl J Med. 335:1996;1388-1389.
35. Antman E.M., Milenko J., Tanasijevic M.J., et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 335:1996;1342-1349.
36. Adams J.E. III, Bodor G.S., Davila-Roman V.G., et al. Cardiac troponin I a marker with high specificity for cardiac injury . Circulation. 88:1993;101-106.
37. Gaspoz J.M., Lee T.H., Cook E.F., et al. Outcome of patients who were admitted to a new short-stay unit to "rule-out" myocardial infarction. Am J Cardiol. 68:1991;145-149.
38. Lloyd-Jones D.M., Camargo C.A., Lapuerta P., et al. Electrocardiographic and clinical predictors of acute myocardial infarction in patients with unstable angina pectoris. Am J Cardiol. 81:1998;1182-1186.
39. Selker H.P., Griffith J.L., D'Agostino R.B. A time-insensitive predictive instrument for acute myocardial infarction mortality a multicenter study . Med Care. 29:1991;1196-1211.
40. Sarasin F.P., Reymond J.M., Griffith J.L., et al. Impact of the acute cardiac ischemia time-insensitive predictive instrument (ACI-TIPI) on the speed of triage decision making for the emergency department patients presenting with chest pain a controlled clinical trial . J Gen Intern Med. 9:1994;187-194.
41. Pozen M.W., D'Agostino R.B., Selker H.P., et al. A predictive instrument to improve coronary-care-unit admission practices in acute ischemic heart disease a prospective multicenter clinical trial . N Engl J Med. 310:1984;1273-1278.
42. Baxt W.G. Analysis of the clinical variables driving decision in an artificial neural network trained to identify the presence of myocardial infarction. Ann Emerg Med. 21:1992;1439-1444.
43. Lindahl B., Venge P., Wallentin L. Early diagnosis and exclusion of acute myocardial infarction using biochemical monitoring. The BIOMACS Study Group. Biochemical Markers of Acute Coronary Syndromes. Coron Artery Dis. 6:1995;321-328.
44. Zimmerman J., Fromm R., Meyer D., et al. Diagnostic marker cooperative study for the diagnosis of myocardial infarction. Circulation. 99:1999;1671-1677.
45. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 329:1993;673-682.
46. Brogan G.X. Jr, Hollander J.E., McCuskey C.F., et al. Evaluation of a new assay for cardiac troponin I vs creatine kinase-MB for the diagnosis of acute myocardial infarction. Acad Emerg Med. 4:1997;6-12.
47. Hollander J.E., Levitt M.A., Young G.P., et al. Effect of recent cocaine use on the specificity of cardiac markers for diagnosis of acute myocardial infarction. Am Heart J. 135:1998;245-252.
48. Adams J.E., Sicard G.A., Allen B.T., et al. Diagnosis of perioperative myocardial infarction with measurement of Ccardiac troponin I. N Engl J Med. 330:1994;670-674.
49. Panteghini M. Diagnostic application of CK-MB mass determination. Clin Chim Acta. 272:1998;23-31.
50. Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Circulation. 59:1979;607-609.
51. WHO criteria for the diagnosis of acute myocardial infarction. Proposal for the multinational monitoring of trends and determinants in cardiovascular diseases. 1981;Cardiovascular Disease Unit of WHO, Geneva.
52. Tunstall-Pedoe H., Kuulasmaa K., Annouyel P., et al. The WHO MONICA project. Myocardial infarction and coronary deaths in the World Health Organization MONICA project. Circulation. 90:1994;588-612.
53. Ryan T.J., Anderson J.L., Antman E.M., et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol. 28:1996;1328-1428.
54. Gillum R.F., Fortmann S.P., Prineas R.J., Kottke T.E. International diagnostic criteria for acute myocardial infarction and acute stroke. Am Heart J. 108:1984;150-158.
55. Hedges J.R., Gibler W.B., Young G.P., et al. Multicenter study of creatine kinase-MB use effect on chest pain clinical decision making . Acad Emerg Med. 20:1991;1220-1228.
56. Wilcox R.G., von der Lippe G., Olsson C.G., Jensen G., Skene A.M., Hampton J.R. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet. 2:1988;525-530.
57. Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial. N Engl J Med. 320:1989;618-627.
58. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction ISIS-2 . Lancet. 2:1988;349-360.
59. Hollander J.E., Lozano M. Jr, Goldstein E., et al. Variations in the electrocardiograms of young adults are revised criteria for thrombolysis necessary? Acad Emerg Med. 1:1994;94-102.